- Home
- BIAF vs TRAW Comparison
BIAF vs TRAW Comparison
Compare BIAF & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- TRAW
- Stock Information
- Founded
- BIAF 2014
- TRAW 1998
- Country
- BIAF United States
- TRAW United States
- Employees
- BIAF N/A
- TRAW N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TRAW
- Sector
- BIAF Health Care
- TRAW
- Exchange
- BIAF Nasdaq
- TRAW NYSE
- Market Cap
- BIAF 12.2M
- TRAW 10.1M
- IPO Year
- BIAF 2022
- TRAW 2013
- Fundamental
- Price
- BIAF $0.75
- TRAW $2.17
- Analyst Decision
- BIAF Hold
- TRAW
- Analyst Count
- BIAF 1
- TRAW 0
- Target Price
- BIAF N/A
- TRAW N/A
- AVG Volume (30 Days)
- BIAF 28.2M
- TRAW 48.8K
- Earning Date
- BIAF 05-14-2025
- TRAW 03-31-2025
- Dividend Yield
- BIAF N/A
- TRAW N/A
- EPS Growth
- BIAF N/A
- TRAW N/A
- EPS
- BIAF N/A
- TRAW N/A
- Revenue
- BIAF $9,362,022.00
- TRAW $226,000.00
- Revenue This Year
- BIAF $25.19
- TRAW $3.81
- Revenue Next Year
- BIAF $20.00
- TRAW N/A
- P/E Ratio
- BIAF N/A
- TRAW N/A
- Revenue Growth
- BIAF 269.68
- TRAW N/A
- 52 Week Low
- BIAF $0.24
- TRAW $2.01
- 52 Week High
- BIAF $3.16
- TRAW $24.75
- Technical
- Relative Strength Index (RSI)
- BIAF 60.32
- TRAW 28.66
- Support Level
- BIAF $0.24
- TRAW $2.01
- Resistance Level
- BIAF $1.55
- TRAW $2.51
- Average True Range (ATR)
- BIAF 0.13
- TRAW 0.27
- MACD
- BIAF 0.08
- TRAW 0.07
- Stochastic Oscillator
- BIAF 38.64
- TRAW 7.63
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.